Oncology Dominates Theranostics Market Amid Rising Global Cancer Burden The global theranostics market reached USD 1.8 billion in 2022 and is projected to grow to USD 4.2 billion by 2031, exhibiting a CAGR of 11.3% during the forecast period 2024–2031, driven by rising demand for personalized and precise medical treatments. Theranostics combines diagnostics and targeted therapy to tailor care based on individual disease profiles, leveraging molecular and...
0 condivisioni
78 Views
0 Anteprima